These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 18547554)

  • 1. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in soman, cyclosarin and tabun-poisoned rats.
    Kassa J; Jun D; Karasova J; Bajgar J; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):425-7. PubMed ID: 18547554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova JZ; Musilek K; Kuca K
    Toxicol Mech Methods; 2009 Jun; 19(5):346-50. PubMed ID: 19778210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
    Kassa J; Jun D; Kuca K; Bajgar J
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
    Berend S; Vrdoljak AL; Radić B; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J; Kuca K; Cabal J; Paar M
    J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova J; Vasina L
    J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Karasova J
    Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Bajgar J
    Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of acetylcholinesterase reactivator dosage on its effectiveness in the treatment of tabun poisoning in mice].
    Kassa J
    Ceska Slov Farm; 2004 Jan; 53(1):31-4. PubMed ID: 15065394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
    Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B
    Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.